Close
Close
Treatment Database
{2-amino-8-[4-(pyrrolidinylcarbonyl)phenyl](3H-benzo[f]azepin-4-yl)}-N,N-dipropycarboxamide
Trade Name not avaiable
Orphan Indication Ovarian cancer
USA Market Approval
USA Designation Date 10-04-2014
Sponsor Celgene Corporation
86 Morris Avenue
Summit, New Jersey, 07901
More about Ovarian cancer
Free Newsletter
Related Videos
by Abidemi Uruejoma
992 views